HEAD AND NECK NEOPLASMS
Clinical trials for HEAD AND NECK NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK NEOPLASMS trials appear
Sign up with your email to follow new studies for HEAD AND NECK NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major cancer trial tests new combo to stop head & neck tumors
Disease control CompletedThis large, completed Phase 3 trial tested whether adding the immunotherapy drug pembrolizumab to standard chemoradiation treatment works better than chemoradiation alone for people with locally advanced head and neck cancer. The study enrolled 804 patients to see if the combinat…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Cancer trial aims to cut harsh treatment side effects
Disease control CompletedThis study compared two standard treatment approaches for advanced head and neck cancer that had spread to lymph nodes. It tested whether performing neck surgery before combined chemotherapy and radiation could reduce severe treatment side effects and improve quality of life, wit…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE3 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug duo tested for Tough-to-Treat head and neck cancers
Disease control CompletedThis study tested whether combining two existing cancer drugs, pembrolizumab and cetuximab, could help control advanced head and neck cancer that had returned or spread. It involved 78 patients at four US cancer centers, grouped based on their prior treatments. The main goal was …
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New pill tested against standard IV drug for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested whether a daily pill called afatinib works better than a standard intravenous chemotherapy (methotrexate) for patients with advanced head and neck cancer that has continued to grow after initial platinum-based treatment. It involved 340 patients and aimed to see…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Cancer trial aims to reduce harsh radiation side effects
Disease control CompletedThis study tested whether using lower radiation doses to healthy neck lymph nodes could reduce long-term side effects while still preventing cancer recurrence. It involved 300 adults with head and neck cancer who were scheduled for curative radiation treatment. Researchers compar…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Workout before treatment may boost cancer Patients' strength
Symptom relief CompletedThis study tested whether a short exercise program before starting cancer treatment helps patients with head and neck cancer. Forty-seven adults scheduled for combined chemotherapy and radiation were randomly assigned to either do exercise training or receive usual care for at le…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: Associacao de Investigacao de Cuidados de Suporte em Oncologia • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
Ozone oil tested to soothe cancer Patients' agonizing mouth sores
Symptom relief CompletedThis study looked back at whether ozone therapy could help cancer patients with severe mouth sores caused by radiation and chemotherapy. It involved 38 patients who received professional ozone treatments and used special ozonated oil at home. Researchers measured if this approach…
Matched conditions: HEAD AND NECK NEOPLASMS
Sponsor: Andrea Scribante • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Nutritional boost tested to ease agony of cancer treatment
Symptom relief CompletedThis study tested whether providing active nutritional support could help head and neck cancer patients receiving radiotherapy. It aimed to see if better nutrition could reduce the painful mouth sores (mucositis) that are a common and debilitating side effect of treatment. The go…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Light vs gas: new hope for easing cancer Treatment's painful side effect
Symptom relief CompletedThis study tested two non-drug treatments to help cancer patients with painful mouth sores, a common and debilitating side effect of chemotherapy and radiation. Forty adults with head, neck, or blood cancers were randomly assigned to receive either laser light therapy or ozone ga…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: University of Pavia • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC
-
Needles vs. fatigue: can ancient practice ease modern cancer treatment?
Symptom relief CompletedThis study tested whether real acupuncture is better than fake acupuncture at helping head and neck cancer patients feel less tired and maintain better blood cell counts during combined chemotherapy and radiation. 34 adult patients were randomly assigned to receive either real or…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: Indonesia University • Aim: Symptom relief
Last updated Mar 16, 2026 15:25 UTC
-
Doctors test High-Tech 3D maps to guide delicate surgery on children
Knowledge-focused CompletedThis study tested a special 3D MRI technique to create detailed maps of nerves in the face and neck of young children. The goal was to see if these maps could help surgeons better plan operations for tumors or birth defects in this delicate area. Seven children aged 1 to 5 who we…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC